Skip to main content

Researchers strive to refill drug discovery ‘pipeline’

Oct. 3, 2011, 10:16 AM

Researchers at Vanderbilt University Medical Center have made substantial progress in developing potential new treatments for Parkinson’s disease, schizophrenia and fragile X syndrome, the most common genetic form of autism.

KEEP READING »

Originally published in VUMC Reporter

Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more